TCF7 and cancer: We propose that the functional cooperation between NELF-dependent Pol II pausing and TCF1 is a mechanism that controls conversion between memory T cells and differentiated effector cells, ultimately dictating antitumor immunity and efficacy of cell-based immunotherapy against cancer.